BMI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.695400E-01
Normal-vs-Stage2
1.951390E-01
Normal-vs-Stage3
3.868400E-02
Normal-vs-Stage4
6.309600E-01
Stage1-vs-Stage2
4.068600E-01
Stage1-vs-Stage3
9.376300E-02
Stage1-vs-Stage4
2.643000E-01
Stage2-vs-Stage3
1.579400E-01
Stage2-vs-Stage4
2.556300E-02
Stage3-vs-Stage4
2.026200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.376200E-01
Normal-vs-AfricanAmerican
6.320600E-01
Normal-vs-Asian
6.148100E-02
Caucasian-vs-AfricanAmerican
3.531600E-01
Caucasian-vs-Asian
1.364190E-01
AfricanAmerican-vs-Asian
7.288400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.551800E-01
Normal-vs-Female
2.320400E-01
Male-vs-Female
9.197000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.693800E-01
Normal-vs-Age(41-60Yrs)
4.582400E-01
Normal-vs-Age(61-80Yrs)
2.021400E-01
Normal-vs-Age(81-100Yrs)
4.984800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.621200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.993000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.090390E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.185210E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.101540E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.530490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.721800E-02
Normal-vs-Daily Drinker
4.330400E-01
Normal-vs-Weekly Drinker
9.468300E-02
Normal-vs-Occasional Drinker
6.208200E-01
Normal-vs-Social Drinker
3.007600E-01
Non Drinker-vs-Daily Drinker
4.077800E-01
Non Drinker-vs-Weekly Drinker
8.121800E-01
Non Drinker-vs-Occasional Drinker
7.017700E-02
Non Drinker-vs-Social Drinker
4.800800E-01
Daily Drinker-vs-Weekly Drinker
5.543200E-01
Daily Drinker-vs-Occasional Drinker
4.648800E-01
Daily Drinker-vs-Social Drinker
9.083200E-01
Weekly Drinker-vs-Occasional Drinker
1.624220E-01
Weekly Drinker-vs-Social Drinker
6.406200E-01
Occasional Drinker-vs-Social Drinker
3.788000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.050800E-01
Normal-vs-Grade 2
1.271210E-01
Normal-vs-Grade 3
1.864830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.045200E-01
Grade 1-vs-Grade 3
9.156000E-01
Grade 1-vs-Grade 4
3.050800E-01
Grade 2-vs-Grade 3
3.745600E-01
Grade 2-vs-Grade 4
1.271210E-01
Grade 3-vs-Grade 4
1.864830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.190000E-01
Normal-vs-NonDiabetic
2.126200E-01
Diabetic-vs-NonDiabetic
3.978400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.165600E-01
Normal-vs-NoPancreatitis
1.974560E-01
Pancreatitis-vs-NoPancreatitis
9.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.866400E-01
Normal-vs-N1
2.006800E-01
N0-vs-N1
6.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.118000E-01
Normal-vs-TP53-NonMutant
3.996400E-01
TP53-Mutant-vs-TP53-NonMutant
5.996000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
